ABSTRACT. Sex reversal due to duplication of the Xp21 dosage-sensitive sex reversal locus results in XY females with gonadal dysgenesis. Pure Xp disomy (without a concurrent loss of genetic material) can occur by translocation or interstitial duplication. The case reported here is the rare form with a t(Xp;Yp). The combination of conventional clinical cytogenetic techniques, microsatellite analysis and high-density microarrays identified the X-chromosome breakpoint as centromeric of the NR0B1 gene and its control elements. Cytogenetics and array technology complemented each other in characterizing the translocation event and the extent of the dosagesensitive sex reversal critical region on the derivative Y-chromosome. The implications of this analysis also lie in genetic counseling that highlight the likely de novo nature of a paternal meiotic event.
INTRODUCTION
Gonadal development is bipotential during the first 7-8 weeks of mammalian embryogenesis. Subsequent differentiation occurs to give rise to testes or ovaries in individuals with a 46,XY or 46,XX karyotype, respectively. The SRY gene plays a pivotal role in testis determination, but several other genes encode for proteins that are required for gonad development. These genes include DHH, LHCGR, SF1, WT1, WNT4, NR0B1 (DAX1) , and SOX9. Mutations in these genes can lead to gonadal disorder of sex development (Table 1) .
Gene
Duplications Haploinsufficiency
DHH
Gonadal dysgenesis +/-polyneuropathy: homozygous point mutation (Umehara et al., 2000; Canto et al., 2004 ) LHCGR Leydig cell hypoplasia and under-virilization in 46,XY male, hypergonadotropic hypogonadism in 46,XX females: heterozygous inactivating mutations (Chan, 1998) 
SF1
Gonadal dysgenesis/agenesis, +/-adrenal insufficiency, 46,XY sex reversal: heterozygous point/microdeletion mutation (Achermann et al., 1999; Correa et al., 2004; Mallet et al., 2004; Hasegawa et al., 2004; Lin et al., 2007; Kohler et al., 2008) ; homozygous point mutation (Achermann et al., 2002 (Jordan et al., 2001) negative loss of function mutation (Biason-Lauber et al., 2004 ) NR0B1 (DAX1) Gonadal dysgenesis, 46,XY Congenital adrenal hypoplasia and hypogonadic hypogonadism ; sex reversal Muscatelli et al., 1994) SOX9 46XX sex reversal (mosaicism of Campomelic dysplasia and gonadal dysgenesis, 46,XY sex reversal: heterozygous duplication; Huang et al., 1999) point mutation (Foster et al., 1994; Cameron et al., 1996) . Table 1 . Genes other than SRY that are implicated in gonadal disorder of sex development.
Of these genes, there are limited reports of individuals carrying duplications of the dosage-sensitive sex reversal (DSS) critical region on the X-chromosome that encompasses the NR0B1 and MAGEB genes (Xp21.2-p21.3) (Barbaro et al., 2007) . Duplication of this region, which would otherwise be subject to X-inactivation, is associated with isolated gonadal dysgenesis together with a range of extragonadal abnormalities (Barbaro et al., 2008) . We report here a 46,X,+mar female carrying a rare unbalanced t(Xp;Yp) rearrangement, together with a high-resolution analysis of the X-chromosome breakpoint.
CLINICAL REPORT
The patient is the first child to a non-consanguineous couple. The mother's pregnancy was unremarkable until the last month when fetal growth retardation was documented. An ultrasound scan at that time demonstrated a hypoplastic corpus callosum and this was confirmed on a postnatal ultrasound. The child was born at term weighing 2.83 kg. She was formula fed and gained weight slowly. At four months of age, a brain magnetic resonance scan showed diffuse thinning of the corpus callosum and in particular the splenium was markedly hypoplastic. Prominence of the lateral ventricles was also noted. At 8 months of age, she was still unable to sit independently. Examination at that time showed her length between the 10th and 25th percentile, weight just below the third percentile and head circumference between the 50th and 75th percentile. She had generalised hypotonia, but she was able to fix and follow and smile. In the facies, there was mild metopic ridging, a bulbous nasal tip, pinched nares with protuberant columella, prominence of the philtral pillars, and a small mouth with normal palate and uvula. She had normal female external genitalia. When last assessed at 2 years of age, she was able to sit, but was not crawling or walking and was able to make simple noises. A pelvic ultrasound performed at 21 months of age demonstrated a normal appearing uterus with dimensions of 23 x 8 x 10 mm. Ovarian tissue was not definitely identified and no testicular tissue was identified. An exploratory laparatomy with removal of any gonadal tissue was advised but has not been performed yet.
Genetic analysis
Conventional chromosome analysis showed a 46,X,+mar karyotype ( Figure 1 ). The marker chromosome was found to be a derivative Y originating from a t(Xp;Yp), using standard fluorescence in situ hybridisation (FISH) analysis. The breakpoint within Yp was distal to the SRY gene, and the additional Xp material was estimated to extend from Xpter to Xp21. Following the result of the patient's 46,X,der(Y)t(X;Y)(p21.1;p11.3) karyotype, a number of Xp21.3-21.2 microsatellite loci were analysed to assess the extent of the duplicated X-chromosome region. Primers were used that had been designed against known sequence-tagged site markers; however, primers were also designed using the FastPCR programme (http://www.biocenter.helsinki.fi/bi/Programs/fastpcr.htm) against di-and tri-nucleotide repeats localised to a small genomic region encompassing the NR0B1 gene (UCSC genome browser; http://genome.ucsc.edu/); see Table 2 . All primers were assessed using SNPcheck (http://ngrl.man.ac.uk/SNPCheck/SNPCheck.html#) to confirm that they did not overlie single-nucleotide polymorphisms. These loci correspond to di-and tri-nucleotide repeats identified in the UCSC genome browser (http://genome.ucsc.edu).
The analysis of the extent of heterozygosity in our patient indicated that the proximal breakpoint on the X-chromosome lay further centromeric than DXS992, and indicated that the patient carried two copies of the NR0B1 gene (accession No. NM_000475; chrX co-ordinates 30232460-30237416 bp according to the NCBI36/hg18 human genome assembly); see Figure 2 . showing sequence-tagged site (STS) microsatellite loci that were used in this study (indicated by blue vertical arrows), together with an amplified view of the region encompassing the NR0B1 gene showing di-and tri-nucleotide repeat loci (L2-L6); these loci are indicated by vertical red arrows. Homozygosity (Hom) and heterozygosity (Het) at the microsatellite loci for the patient described here are indicated.
To achieve more precision concerning the extent of the duplicated X-chromosome region, chromosomal microarray analysis (CMA) was performed on DNA extracted from peripheral blood using the Affymetrix ® Cytogenetics Whole-Genome 2.7M Array, according to manufacturer instructions. Regions of copy number change were calculated using the Affymetrix Chromosome Analysis Suite software (ChAS) v.1.0.1.
Array analysis determined a complete complement of the male-specific Y-chromosome region and then confirmed the presence of the SRY gene identified by FISH. A large duplication of the distal Xp-region was estimated to comprise from Xpter to within Xp21.1 (chromosome co-ordinates X: 1-31,656,721). This region encompasses the NR0B1 and MAGEB genes, and precisely mapped the proximal X-chromosome breakpoint to intron 52 of the dystrophin gene (Figure 3 ). The analysis of this intronic region shows repetitive elements such as AluY (CENSOR; Kohany et al., 2006 ; http://www.girinst.org/censor/index.php). Despite the resolution afforded by the Affymetrix array used here, the data do not enable any conclusion to be made regarding the mechanism of the translocation event, which is likely to involve non-homologous end-joining as opposed to non-allelic homologous recombination (Erdogan et al., 2006; Chen et al., 2008) . 
DISCUSSION
Sex reversal due to Xp21 disomy is rare and has been observed as a result of an interstitial duplication of Xp21, an X;A translocation or an X;Y translocation (Sanlaville et al., 2004; Barbaro et al., 2007 Barbaro et al., , 2008 Tzschach et al., 2008) . The patient reported here is one of a small number of reported cases resulting from an X;Y translocation (Table 3) , and the only one that has been resolved at the level of oligonucleotide-based CMA. Four of these patients had female external genitalia, and one was ambiguous. Most had no identifiable gonadal tissue by ultrasound; one had streak gonads that went on to develop gonadoblastoma. All exhibited mental retardation, hypotonia, and dysmorphic facial features.
The extent of the extragonadal abnormalities observed in these individuals nominally relates to the size of the duplicated X-chromosome segment. However, the correlation of genotype and extragonadal phenotype is difficult in these cases due to the large number of duplicated genes involved and the absence of precise breakpoint characterisation. In addition, factors such as gene disruption or positional effects due to translocation may also play a role in phenotypic variability, including the DSS phenotype. There is at least one t(X;Y) SRY+ case reported with duplication of the NR0B1 gene, but only partial gonadal dysgenesis (Table 3) . It has been suggested that the Xp breakpoint in this case may have disrupted the 5' regulatory Karyotype Phenotype Reference 46,X,der(Y)t(X;Y)(p21;p11.3) Female external genitalia, developmental delay/mental retardation, hypotonia, dysmorphic facial features, Ogata et al., 1992 psychomotor retardation, streak gonads, gonadoblastoma, autoimmune disease.
46,X,der(Y)t(X;Y)(p21.3;q11.21) * Ambiguous external genitalia, mental retardation, muscular hypotrophy, dysmorphic facial features, Bardoni et al., 1993 psychomotor retardation, hypotrophic intra-abdominal testes, growth retardation.
46,X,der(Y)t(X;Y)(p21.1;q11) Female external genitalia, developmental delay/mental retardation, hypotonia dysmorphic facial features, Bajalica et al., 1995 no identifiable gonads by ultrasound, growth retardation.
46,X,der(Y)t(X;Y)(p21;q11) Ambiguous external genitalia, developmental delay/mental retardation, hypotonia, dysmorphic facial features, Vasquez et al., 1999 psychomotor retardation, growth retardation (gonads not examined).
46,X,der(Y)t(X;Y)(p21.2;p11.3) Female external genitalia, developmental delay/mental retardation, hypotonia, dysmorphic facial features, Sanlaville et al., 2004 no identifiable gonads by ultrasound, growth retardation, partial agenesis of the corpus callosum.
46,X,der(Y)t(X;Y)(p21.1;p11.3) Female external genitalia, developmental delay/mental retardation, hypotonia, dysmorphic facial features, Present case no identifiable gonads by ultrasound, slight growth retardation, partial agenesis of the corpus callosum. region of the NR0B1 gene resulting in incomplete DSS (Barbaro et al., 2008) . In contrast, the patient reported here has a breakpoint that is further centromeric, containing the entire NR0B1 gene and control elements and therefore exhibiting complete DSS.
The risk of developing a gonadal malignancy for these patients is the same as those faced by other phenotypic females who carry Y-chromosome material. Therefore pre-emptive removal of the gonadal tissue is often recommended. The X;Y translocated forms of Xp21 duplication are isolated events, which arise de novo during paternal meiosis. This is in contrast to patients with interstitial Xp21 duplications and X;A translocations, which can be inherited from phenotypically normal female carriers (Barbaro et al., 2007) . These scenarios have significantly different genetic counselling implications with family studies a likely recommendation in the latter two instances.
Until recently, the diagnosis of cases with X;Y translocations was characterised using GTG-banding and FISH. The latter method requires multiple rounds of testing, which is time-consuming and expensive. In contrast, the combination of GTG-banding and CMA used here is more straight forward. Critically, neither conventional GTG-banding nor CMA alone could detect both the presence of the DSS locus and the translocation in the patient reported here. Therefore, together, these techniques aid in identifying chromosome rearrangements and dosage changes in genes that play a pivotal role in disorders of sex development.
